Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Synlait Milk ingredient will help to enhance sleep

Synlait Milk ingredient will help to significantly enhance sleep

Synlait Milk has commercialised a dairy-based milk powder ingredient that is clinically proven to enhance sleep.

Results from an independent clinical trial of iNdream3 have proved its efficacy as a sleep promoting ingredient.

iNdream3 is made from melatonin-rich milk collected in the hours of darkness, when cows naturally produce increased concentrations of melatonin in their milk.

“We’ve been developing this product for several years and this clinical trial is a major milestone in proving the ability of iNdream3 to improve sleep,” said Dr Simon Causer, Synlait’s Research and Development Manager.

“iNdream3 leverages melatonin in its natural form. Melatonin in almost all other products are synthetically produced or extracted from source materials with lower levels of melatonin.”

Melatonin is a sleep-promoting hormone that plays a key role in helping humans to regulate their day/night cycle.

iNdream3 has initially been sold in Korea by a Synlait customer since January 2015. Their product, Sleepiz, is sold as a powder in a sachet that consumers reconstitute as a drink.

The clinical trial, conducted by Otago University’s WellSleep Centre, found that iNdream3 reduces the time to onset of sleep, increases stage N3 sleep time (the deepest phase of sleep) and reduces daytime dysfunction. Daytime dysfunctions include sleepiness, fatigue, impaired memory and poor concentration.

“iNdream3 is an exciting opportunity. It demonstrates our capability as a nutritional business to create and add value for the long term,” said Dr John Penno, Synlait’s Managing Director.

“This is a high value product. Both Synlait and our milk suppliers who provide night milk will benefit, with suppliers receiving a payment above the market milk price," said Dr Penno.

“We are looking forward to continuing to develop opportunities with our business to business (B2B) customers for the use of iNdream3 as an ingredient in their products.”

Development of this product was funded by Synlait with additional support from DairyNZ through the Transforming the Dairy Value Chain Primary Growth Partnership programme.

The clinical trial was conducted by Otago University and jointly funded by Synlait, New Zealand Trade and Enterprise (NZTE) and Ingredia SA.
ENDS

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Primary Sector Council Report: Vision To Unite The Primary Sector Launched

Agriculture Minister Damien O’Connor has welcomed the release of a bold new vision for the country’s vital food and fibre sector. More>>

ALSO:

Crown Accounts: Treasury HYEFU Sees Deficit Then Rising Surpluses

An operating balance before gains and losses deficit of $0.9 billion is forecast in the current year, before returning to a small surplus in 2020/21 which then grows to reach $5.9 billion (1.5% of GDP) in 2023/24. More>>

ALSO:

Fuels Rushing In: Govt "Ready To Act" On Petrol Market Report

The Government will now take the Commerce Commission’s recommendations to Cabinet...
• A more transparent wholesale pricing regime • Greater contractual freedoms and fairer terms • Introducing an enforceable industry code of conduct • Improve transparency of premium grade fuel pricing... More>>

ALSO:

Reserve Bank Capital Review Decision: Increased Bank Capital Requirements

Governor Adrian Orr said the decisions to increase capital requirements are about making the banking system safer for all New Zealanders, and will ensure bank owners have a meaningful stake in their businesses. More>>

ALSO: